Get the Stockscreener App
187.58
0.39%
0.73
After Hours:
187.58
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $187.58, with a volume of 1.41M.
It is up +0.39% in the last 24 hours and up +2.63% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$186.85
Open:
$185.6
24h Volume:
1.41M
Relative Volume:
1.51
Market Cap:
$20.98B
Revenue:
$10.52B
Net Income/Loss:
$999.00M
P/E Ratio:
22.43
EPS:
8.3628
Net Cash Flow:
$1.22B
1W Performance:
+6.27%
1M Performance:
+2.63%
6M Performance:
+7.50%
1Y Performance:
+16.84%
1-Day Range:
$184.50
$190.47
1-Week Range:
$175.76
$191.31
52-Week Range:
$148.70
$197.55
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
187.58 | 20.79B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
580.13 | 220.92B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.20 | 154.97B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.48 | 56.98B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.89 | 42.96B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
223.55 | 37.62B | 15.90B | 1.28B | 2.21B | 7.2842 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-17-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-28-24 | Resumed | Evercore ISI | In-line |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Using flow based indicators on Quest Diagnostics IncorporatedWeekly Investment Recap & Entry Point Confirmation Signals - newser.com
3rd Circ. Says Quest Didn't Eavesdrop In Data Privacy Suit - Law360
Is Quest Diagnostics Incorporated stock nearing a technical breakoutEarnings Risk Report & Weekly Top Stock Performers List - newser.com
Will Quest Diagnostics Incorporated (QDI) stock beat international competitionJuly 2025 Levels & Reliable Momentum Entry Alerts - newser.com
Will Quest Diagnostics Incorporated stock gain from lower inflationJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com
Quest Diagnostics Incorporated stock trend forecastTrade Volume Summary & Growth Focused Stock Reports - newser.com
How to build a dashboard for Quest Diagnostics Incorporated stockWeekly Trade Recap & Daily Risk Controlled Trade Plans - newser.com
Is Quest Diagnostics Incorporated (QDI) stock positioned for secular growthJuly 2025 Sentiment & AI Based Buy/Sell Signal Reports - newser.com
Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance
Quest Diagnostics Solidifies Shareholder Value with $0.80 Quarterly Dividend - Markets Financial Content
Quest Diagnostics (NYSE: DGX) Bolsters Shareholder Confidence with Latest Dividend Declaration - Markets Financial Content
Quest Diagnostics Incorporated Declares Quarterly Cash Dividend, Payable on January 28, 2026 - MarketScreener
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics Keeps Quarterly Dividend at $0.80 a Share, Payable Jan. 28, 2026, to Holders of Record Jan. 13 - MarketScreener
Quest Diagnostics declares quarterly cash dividend of $0.80 By Investing.com - Investing.com Canada
Quest Diagnostics Declares Quarterly Cash Dividend - MarketScreener
Quest Diagnostics Declares Quarterly Cash Dividend - Benzinga
Quest Diagnostics (DGX) is a Top-Ranked Growth Stock: Should You Buy? - sharewise.com
Why Quest Diagnostics Incorporated stock is favored by top institutionsJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com
DGX SEC FilingsQuest Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
What Fibonacci levels say about Quest Diagnostics Incorporated reboundWeekly Market Summary & Reliable Intraday Trade Alerts - newser.com
Published on: 2025-11-10 01:15:37 - newser.com
Published on: 2025-11-09 23:17:14 - newser.com
Quest Diagnostics Incorporated stock outlook for YEARTrade Entry Summary & Reliable Trade Execution Plans - newser.com
Why Quest Diagnostics Incorporated stock is a strong buy call2025 Price Momentum & Verified Trade Idea Suggestions - newser.com
Published on: 2025-11-08 11:00:37 - newser.com
[Form 4] QUEST DIAGNOSTICS INC Insider Trading Activity - Stock Titan
How supply chain issues affect Quest Diagnostics Incorporated stock2025 Performance Recap & Real-Time Volume Analysis - newser.com
Is Quest Diagnostics Incorporated stock in correction or buying zonePortfolio Update Summary & Pattern Based Trade Signal System - newser.com
Can Quest Diagnostics Incorporated stock surprise with earnings upside2025 Earnings Impact & Technical Pattern Recognition Alerts - newser.com
Why Quest Diagnostics Incorporated stock is recommended by analystsJuly 2025 EndofMonth & Long Hold Capital Preservation Plans - Fundação Cultural do Pará
Why Quest Diagnostics Incorporated stock is favored by hedge fundsPortfolio Gains Report & Verified Stock Trade Ideas - newser.com
Can Quest Diagnostics Incorporated (QDI) stock deliver double digit returnsMarket Weekly Review & Stepwise Trade Execution Plans - Fundação Cultural do Pará
Forecasting Quest Diagnostics Incorporated price range with options dataRecession Risk & High Return Stock Watch Alerts - newser.com
Will Quest Diagnostics Incorporated (QDI) stock enhance shareholder valueJuly 2025 Trade Ideas & Growth Oriented Trading Recommendations - Fundação Cultural do Pará
Marion Wealth Management Makes New Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
TKG Advisors LLC Buys Shares of 6,484 Quest Diagnostics Incorporated $DGX - MarketBeat
State of Michigan Retirement System Sells 2,396 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Atria Investments Inc Purchases 2,599 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Incorporated stock cheap compared to fundamentalsRisk Management & Community Consensus Stock Picks - newser.com
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.70%
2.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):